Novus Therapeutics
Why Robinhood?
You can watch NVUS and buy or sell other stocks, ETFs, and their options commission-free!About NVUS
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in development of therapies to protect transplanted organs and prevent rejection. The firm also focuses on development of therapy to treat amyotrophic lateral sclerosis.
NVUS Key Statistics
Stock Snapshot
With a market cap of 701.5M, Novus Therapeutics(NVUS) trades at $9.30. The stock has a price-to-earnings ratio of -5.16.
Novus Therapeutics(NVUS) stock opened on 2026-04-03 at —. The price climbed to — and dipped to —.
The Novus Therapeutics(NVUS)'s current trading volume is 0, compared to an average daily volume of 1.54M.
During the past year, Novus Therapeutics(NVUS) stock moved between $1.35 at its lowest and $4.60 at its peak.
During the past year, Novus Therapeutics(NVUS) stock moved between $1.35 at its lowest and $4.60 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.